Simply because folks who carry the APOE e4 gene variant appear to have a bigger threat of significant difficulties, the FDA recommends staying tested for the gene variant before starting treatment with lecanemab or donanemab.Tests for dementia supply 1 piece of the puzzle. They should not substitute for an entire diagnostic evaluation, which can al